Cite
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
MLA
Read, Robert C., et al. “Effect of a Quadrivalent Meningococcal ACWY Glycoconjugate or a Serogroup B Meningococcal Vaccine on Meningococcal Carriage: An Observer-Blind, Phase 3 Randomised Clinical Trial.” Lancet, vol. 384, no. 9960, Dec. 2014, pp. 2123–31. EBSCOhost, https://doi.org/10.1016/S0140-6736(14)60842-4.
APA
Read, R. C., Baxter, D., Chadwick, D. R., Faust, S. N., Finn, A., Gordon, S. B., Heath, P. T., Lewis, D. J. M., Pollard, A. J., Turner, D. P. J., Bazaz, R., Ganguli, A., Havelock, T., Neal, K. R., Okike, I. O., Morales-Aza, B., Patel, K., Snape, M. D., Williams, J., & Gilchrist, S. (2014). Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet, 384(9960), 2123–2131. https://doi.org/10.1016/S0140-6736(14)60842-4
Chicago
Read, Robert C., David Baxter, David R. Chadwick, Saul N. Faust, Adam Finn, Stephen B. Gordon, Paul T. Heath, et al. 2014. “Effect of a Quadrivalent Meningococcal ACWY Glycoconjugate or a Serogroup B Meningococcal Vaccine on Meningococcal Carriage: An Observer-Blind, Phase 3 Randomised Clinical Trial.” Lancet 384 (9960): 2123–31. doi:10.1016/S0140-6736(14)60842-4.